Skip to main content
SQI Diagnostics Inc. logo

SQI Diagnostics Inc. — Investor Relations & Filings

Ticker · SQD.H ISIN · CA78466B1085 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 121 across all filing types
Latest filing 2024-01-19 Regulatory Filings
Country CA Canada
Listing TSXV SQD.H

About SQI Diagnostics Inc.

https://www.sqidiagnostics.com

SQI Diagnostics Inc. is a precision medicine and biotechnology company specializing in the discovery, development, and commercialization of innovative diagnostic solutions. The company utilizes proprietary technologies, including advanced microarray diagnostics, to evolve laboratory-based biomarker testing. SQI Diagnostics focuses on critical health areas, positioning itself as a leader in lung health and providing tests targeting organ transplant monitoring, autoimmune diseases, and infectious diseases. Its solutions serve the needs of the human diagnostic testing market and the pharmaceutical and biotechnology sectors for drug development.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1) (amended).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, distribution dates, purchaser information, compensation related to the distribution, and regulatory references to Canadian securities laws. It is a regulatory filing form used to report exempt distributions of securities, not a financial report, earnings release, or management discussion. The content is consistent with a regulatory compliance filing rather than a financial report or announcement. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive regulatory filing form.
2024-01-19 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of SQI Diagnostics Inc.'s financial and operational results for the second quarter ended March 31, 2023. It includes specific financial figures such as sales, gross profit, expenses, net loss, cash position, and working capital deficit. It also discusses corporate highlights, liquidity, going concern risks, and management commentary. The presence of comprehensive financial data and operational analysis for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document is not merely an announcement of a report publication or a brief earnings release; it contains substantive financial data and management discussion. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-05-31 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the Chief Financial Officer of SQI Diagnostics Inc. regarding the interim financial report and interim MD&A for the period ended March 31, 2023. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The text explicitly states it is a certification of the interim filings, not the filings themselves. The document length is 3007 characters, which is relatively short and consistent with a certification letter rather than a full interim report. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). Therefore, this document is best classified as a Regulatory Filing (RNS).
2023-05-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CEO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2023. The text is primarily a certification letter without actual financial data or detailed financial statements. It references the interim filings but does not contain the filings themselves. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is about 3000 characters, which is short and consistent with a certification letter rather than a full interim report.
2023-05-31 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements (Unaudited)' for the three and six months ended March 31, 2023 and 2022. It contains detailed financial statements including statements of financial position, loss and comprehensive loss, cash flows, and notes to the financial statements. The presence of interim period financial data and analysis, such as revenues, expenses, net loss, cash flows, and detailed notes, indicates this is a comprehensive interim financial report. The document is approximately 15,000 characters long, which is consistent with a full interim report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-05-31 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis of Financial Condition and Results of Operations' for the six months ended March 31, 2023. It contains detailed management commentary on financial condition, results of operations, business strategy, product pipeline, restructuring, and outlook. It references interim financial statements and discusses forward-looking statements, strategic objectives, and operational highlights. The length is substantial (15,000 characters), and it contains substantive financial and operational analysis rather than just an announcement or certification. This matches the characteristics of an Interim / Quarterly Report (IR) which includes comprehensive financial data and management analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is IR with high confidence.
2023-05-31 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.